
Ralliant Corp. (RAL) Market Cap
Ralliant Corp. has a market capitalization of $6.74B.
Price: $60.17
▼ -2.26 (-3.62%)
Market Cap: 6.74B
NYSE · time unavailable
CEO: Tamara S. Newcombe
Sector: Industrials
Industry: Aerospace & Defense
IPO Date: 2025-06-25
Website: https://ralliant.com/
Ralliant Corp. (RAL) - Company Information
Market Cap: 6.74B|Sector: Industrials
Company Profile
Ralliant Corporation specializes in the design, development, and manufacturing of precision instruments and engineered products. The company offers test and measurement systems, advanced specialty sensors, and subsystems for defense and space applications.
Analyst Sentiment
From 12 Active Polls
1Y Forecast: $59.17
▼ -1.7% Potential Upside
Consensus Target Metrics
Low Bound
$45
Median
$65
High Bound
$67
Average
$59
Price & Moving Averages
🎯 Wall Street Analyst Intelligence Report
1-Year structural target targets, chart projections, and sentiment maps.
Consensus Trend Projection
Trailing closures vs. 12-month metrics map.
Analyst Vote Distribution
Aggregate institutional coverage sentiment weights.
📊 Historical Valuation Multiples
Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.
| Fiscal Quarter | TTM | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Trailing 12M | Apr 3, 2026 | Dec 31, 2025 | Sep 26, 2025 | Jun 27, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
| Market Cap ($M) | 6,735 | 4,721 | 5,748 | 4,919 | 5,971 | 5,367 | 5,367 | 5,367 | 5,367 |
| Enterprise Value ($M) | 7,615 | 5,601 | 6,578 | 5,804 | 6,921 | 6,364 | 5,439 | — | — |
| Price to Earnings Ratio (P/E) | -5.44 | 26.70 | -1.05 | 30.82 | 31.36 | 21.00 | 43.14 | 14.76 | 20.71 |
| Price/Earnings-to-Growth Ratio (PEG) | — | — | -0.22 | 6.01 | 7.03 | — | 13.99 | — | — |
| Price to Sales Ratio (P/S) | 3.17 | 8.83 | 10.36 | 9.30 | 11.86 | 11.14 | 9.79 | 10.09 | 10.06 |
| Price to Book Ratio (P/B) | 4.32 | 3.02 | 2.81 | 1.66 | 1.96 | 1.88 | 1.43 | — | — |
| Price to Free Cash Flow Ratio (P/FCF) | 22.33 | 491.75 | 62.75 | 38.86 | 80.91 | 80.83 | 36.61 | 40.69 | 62.12 |
| Enterprise Value to Sales (EV/Sales) | — | 10.48 | 11.86 | 10.97 | 13.75 | 13.21 | 9.92 | — | — |
| Enterprise Value to EBITDA (EV/EBITDA) | 20.54 | 57.27 | 63.31 | 71.21 | 79.09 | 63.51 | 59.70 | — | — |
| Debt to Equity Ratio | 2.37 | 0.73 | 0.56 | 0.39 | 0.38 | 0.40 | 0.02 | — | — |
⚡ RAL Growth Runway Model
Standard long term linear growth fadeMulti-Stage Discounted Cash Flow Sandbox
Growth runway slowdown
This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.Terminal growth rate
With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.3-Stage Financial Runway Horizon
🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)
📘 Full Research Report
AI-Generated Research: This report is for informational purposes only.
📰 Market News & Coverage
15 Stories AvailableReal-time institutional reporting and market updates for RAL.
Related Companies in Industrials
📊 AI Financial Analysis
Powered by StockMarketInfo"RAL reported Q1 2026 revenue of $534.6M and net income of $44.2M (EPS $0.39). QoQ, revenue declined 3.7% ($554.6M in Q4 2025 to $534.6M), while net income swung from a loss in Q4 2025 (-$1.39B) to a profit (+$44.2M). YoY, revenue increased 11.0% versus Q1 2025 ($481.8M), and net income decreased 13.3% versus Q1 2025 ($51.0M), implying earnings normalized from last year’s stronger quarter. Profitability improved sequentially: net margin was 8.3% in Q1 2026 versus -251.3% in Q4 2025, and gross margin was broadly steady (50.9% vs 50.5% QoQ; 50.9% vs 50.5% YoY). Operating cash flow was $19.1M and free cash flow was $10.4M in Q1 2026—far lower than Q4 2025’s strong operating cash generation ($101.6M) and Q1 2025’s $72.0M. Cash fell 15.9% QoQ (from $318.8M to $268.0M) alongside buyback activity: the company repurchased $50.5M of stock and paid $5.6M in dividends in the quarter. Balance sheet resilience appears mixed: total assets were $3.70B (down 3.4% QoQ), while total equity was $1.57B (down sharply from $2.04B QoQ). Debt and net debt remain elevated ($1.15B total debt; $880.3M net debt), and investment/FCF coverage in the quarter was modest. Total shareholder returns are currently modest based on price (1y_change -0.21%); no buyback magnitude data beyond repurchases in this quarter is provided in the price inputs."
Revenue Growth
YoY revenue +11.0% ($481.8M to $534.6M). QoQ revenue -3.7% ($554.6M to $534.6M), indicating soft sequential demand/seasonality.
Profitability
QoQ net income improved materially from a very large loss in Q4 2025 to +$44.2M in Q1 2026. YoY net income -13.3% and net margin slipped vs Q1 2025 (8.3% vs 10.6%), though gross margin is steady (~50.5–50.9%).
Cash Flow Quality
Operating cash flow was $19.1M and free cash flow $10.4M in Q1 2026, below Q4 2025 (OCF $101.6M; FCF $91.6M) and far below Q1 2025 (OCF $72.0M; FCF $66.4M). Cash decreased QoQ while repurchases/dividends occurred.
Leverage & Balance Sheet
Total assets declined to $3.70B QoQ and equity fell to $1.57B from $2.04B, suggesting weaker balance sheet quality/securitization or accumulated earnings effects. Debt remains sizable ($1.15B), with net debt ~$880M.
Shareholder Returns
Price momentum is slightly negative (1y_change -0.21%). In Q1 2026, the company returned capital via buybacks (-$50.5M) and dividends (-$5.6M), but cash/FCF coverage in the quarter was limited.
Analyst Sentiment & Valuation
Consensus price target implies upside: current price $47.4 vs target consensus $46 (roughly flat/slightly below). Valuation metrics provided show price-to-earnings is not directly comparable due to quarter variability.
Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.
Fundamentals Overview
Ral’s Q1 2026 results delivered clear upside versus the high end of guidance: revenue grew 11% reported (+9% organic), book-to-bill exceeded 1.1x, adjusted EBITDA margin reached 18.6%, and adjusted EPS was $0.57—both above guidance ranges. The normalized margin story is especially strong: adjusted EBITDA margin improved 270 bps YoY and Test & Measurement added +700 bps normalized, supported by operating leverage and early enterprise productivity actions. Management raised full-year 2026 outlook across revenue, margin, and EPS, citing elevated Test & Measurement orders and a defense backlog now above $1B. Capital allocation tightened further with a $500M repurchase authorization and a $100M accelerated repurchase in Q2, targeting ~50% of free cash flow returns (FCF conversion remains resilient at 105%, above a >95% target). Key risks flagged were 2H macro/supply uncertainty and potential lumpy defense fee dynamics during backlog transitions, partially offset by high visibility from 90–120 day short-cycle funnels.
Growth Catalysts
- Defense & Space demand: multiyear defense backlog surpassed $1 billion; Defense & Space delivered >20% organic growth and robust replenishment/missiles & munitions shipments
- Test & Measurement rebound: returned to growth; highest quarterly book-to-bill since 2022 (between 1.1 and 1.2)
- Utilities strength: record orders reinforcing grid modernization/resiliency; utilities order strength improved visibility despite shipment-timing softness
- Semiconductor/Test & Measurement strength excluding laps: underlying CapEx-driven growth in power-related semiconductors (esp. wideband gap) after lapping a large customer credit
Business Development
- Defense modernization / priority munitions programs: supplier to the majority of the Pentagon’s priority munitions programs, including FAD, PAC-3, and Tomahawk (capacity scaling at ~2 to 5x historic levels)
- Portfolio backlog is customer-funded innovation in defense modernization: new-product programs up ~60% over the last 2 years (customer-funded, not surge-demand)
Financial Highlights
- Revenue $535M, +11% YoY reported and +9% organic; book-to-bill above 1.1x; both segments posted 9% organic revenue growth
- Q1 above guidance high end: adjusted EBITDA margin 18.6% (above high end of guidance); adjusted EPS $0.57 (above high end of guidance); normalized adjusted EBITDA margin +270 bps YoY
- EPS performance: adjusted diluted EPS +39% on a normalized basis driven by revenue growth and adjusted EBITDA margin expansion
- FCF conversion: trailing 12-month free cash flow conversion 105% vs target >95%; Q1 free cash flow $10M (down YoY due to timing)
- Segment margins: Sensors & Safety Systems adjusted EBITDA margin 28.4% (+70 bps normalized); Test & Measurement adjusted EBITDA margin 11.9% (+700 bps normalized)
- FX tailwind: total growth included ~2 percentage points FX benefit (primarily Western Europe and China)
Capital Funding
- Shareholder returns increased: $56M returned in Q1 via dividends and share repurchases
- Board authorization raised to $500M; targeting repurchases at ~50% of free cash flow going forward
- Accelerated share repurchase planned: $100M ARP in Q2
- Balance sheet liquidity: cash and cash equivalents $268M at quarter end
- Debt/capital structure: refinanced 18-month term loan; extended maturity and amended covenants (favorable terms)
Strategy & Ops
- Enterprise productivity program initiated/expanded: target $50M to $60M run-rate annualized savings by 2028; reporting team to CEO; RBS used to identify/track workflows and sustainment
- Savings progress: acted on ~ $20M of run-rate annualized savings to date; Q1 actions added ~ $10M annualized savings; 2026 in-year savings expected $10M to $12M (exiting 2026 at ~$20M annualized run-rate)
- Cost-of-sales initiatives: enterprise strategic sourcing and new group purchasing office
- G&A initiatives: simplification, AI-enhanced workflows, leveraging lower-cost locations to optimize labor
- Capacity expansion plans: expand precision sensor facility in Upstate New York later in 2026 (utilities demand support); defense capacity expansion ongoing with productivity/sourcing focus, with expectation of additional physical capacity toward out years
- Operations guidance sensitivity: short-cycle businesses have ~90 to 120 days visibility
Market Outlook
- Q2 2026 guidance: revenue $540M to $556M; 7% to 10% YoY organic; adjusted EBITDA margin 18.5% to 19.5%; adjusted EPS $0.58 to $0.64
- Q2 share count assumption: weighted average diluted shares ~112M after $100M accelerated repurchase
- Full-year 2026 updated guidance: revenue $2.185B to $2.245B; adjusted EBITDA margin 19.5% to 20.5%; adjusted EPS $2.53 to $2.69
- Incremental margin framework (2026 through 2028): 2026 assumes 35% to 40% baseline incremental adjusted EBITDA margin excluding productivity savings; productivity savings add ~10 percentage points incremental margin (total 45% to 50% for 2026); 2027–2028 incremental targets ~50%
Risks & Headwinds
- Macro uncertainty and potential supply disruptions in 2H 2026 cited as a reason to remain cautious on second-half demand despite strong cycle momentum
- Seasonality and quarter-to-quarter lumpy fees for defense products during backlog transition (lumpiness in both revenue and margins expected)
- Mix headwinds: defense strong growth carries some margin impact (defense products at margins below company average); utilities and defense mix can be lumpy
- Test & Measurement semis category: near-term lapping of a large customer credit continues to affect reported semiconductor organic revenue (partial headwind already mentioned)
Q&A: Analyst Interest
- Sales growth and 2H phasing: Management explained that T&M drove the full-year raise via Q1 order strength and book-to-bill, with 90–120 days visibility. They noted seasonal mix (approx. 48% 1H / 52% 2H historically) and said macro and supply-disruption uncertainty may keep 2H nearer the top end, not below.
- EBITDA margin outlook and 2H moderation: Management said margin performance is driven by a revenue-growth formula plus mix headwinds and the enterprise productivity program’s cost optimization. They did not frame it as a single factor but emphasized those three drivers—growth, mix, and productivity execution—as the reason 2H expansion is more muted.
- Defense backlog conversion to capacity and growth: Management clarified $1B backlog as a multiyear (2–3 years) order stream, with replenishment programs dominating and real orders supporting on-time delivery. They said capacity expansion has been underway for over 2 years via productivity and strategic sourcing, with potential additional physical capacity needed into out-years.
Sentiment: POSITIVE
Note: This summary was synthesized by AI from the RAL Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.
📋 Official Regulatory 10-K / 10-Q SEC Filings
Direct authenticated documentation links to audited SEC database reports for RAL.




















